Best Biotech Stocks To Invest In Right Now


Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) is one of the biggest names in the biotechnology sector. The company has already-approved assets (of which there are six so far) and pipeline-based development drugs (of which there are around 15 right now) designed to target a whole host of different indications, from eye disease to heart disease, to pain, cancer, infectious diseases and rare diseases.

You name it, Regeneron is likely going after it.

Well, the company just made an announcement that adds another indication target to the above list and, on the back of the development, has made a move rarely seen in the biotechnology and health care sectors these days — but one that was incredibly popular during the latter third of last century.


Here is a look at the development in question with a discussion of what it means for Regeneron and for the patients that form the population that the company is now targeting.

Best Biotech Stocks To Invest In Right Now: Avid Technology Inc.(AVID)

Advisors’ Opinion:

  • [By Lisa Levin]

    Avid Technology, Inc. (NASDAQ: AVID) shares were also up, gaining 24 percent to $5.01 following Q3 results. Avid Technology reported Q3 earnings of $0.00 per share on revenue of $105.26 million.

  • [By Monica Gerson]

    Avid Technology, Inc. (NASDAQ: AVID) is estimated to post its quarterly earnings at $0.36 per share on revenue of $144.02 million.

    Consolidated Water Co. Ltd. (NASDAQ: CWCO) is expected to post its quarterly earnings at $0.11 per share on revenue of $15.15 million.

  • [By Anders Bylund]

    Shares of Avid Technology(NASDAQ:AVID) rose 20.3% in April 2017, according to data from S&P Global Market Intelligence.

    So what

    Last month’s share price surge rested on Avid’s release of a coherent cloud-based media production suite. The new version of Avid’s MediaCentral platform takes advantage of the cloud, central storage, and back-end data processing in a way older versions never attempted, modernizing the media production tool in a big way.

Best Biotech Stocks To Invest In Right Now: Colony NorthStar, Inc. (CLNS)


Advisors’ Opinion:

  • [By Paul Ausick]

    Colony NorthStar Inc. (NYSE: CLNS) dropped about 3.1% Friday to post a 52-week low of $10.36 after closing at $10.69 on Thursday. The 52-week high is $14.92. Volume was around 6.1million, more than double the daily average. The company had no specific news.

  • [By Paul Ausick]

    Colony NorthStar Inc. (NYSE: CLNS) slipped about 3.1% to post a new 52-week low of $11.02 Wednesday after closing at $11.37 on Tuesday. Volume of about 3.8 million was about 45% above the daily average of around 2.7 million. The REIT completed its sale of an investment management firm to Aon plc on Tuesday for net proceeds of around $379 million.

  • [By Paul Ausick]

    Colony NorthStar Inc. (NYSE: CLNS) posted a new 52-week low of $11.97 Friday, down a penny after closing at $12.08 on Thursday. The 52-week high is $16.08. Volume was about 4 million, more than 50% above the daily average of around 2.6 million shares. The company had no specific news.

  • [By Paul Ausick]

    Colony NorthStar Inc. (NYSE: CLNS) matched a 52-week low of $11.97 set last Friday. The 52-week high is $16.08. Volume was about 2.5 million, nearly equal to the daily average of around 2.6 million shares. The company had no specific news. Shares are on track to close with a gain of nearly 1%.

  • [By Paul Ausick]

    Colony NorthStar Inc. (NYSE: CLNS) dropped about 2.4% Thursday to post a 52-week low of $10.69 after closing at $10.95 on Wednesday. The 52-week high is $14.92. Volume was around 5.3 million, nearly double the daily average. The company had no specific news.

Best Biotech Stocks To Invest In Right Now: Goldfield Corporation (The)(GV)

Advisors’ Opinion:

  • [By Jim Robertson]

    Just before Thanksgiving, our Under the Radar Moversnewsletter suggested buying small cap electrical infrastructure stockGoldfield Corp (NYSEMKT:GV):